harmalol has been researched along with riboflavin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, AA; Arnold, LA; Bateman, R; Baxter, JD; Estébanez-Perpiñá, E; Fletterick, RJ; Guy, RK; Mar, E; Nguyen, P; Pallai, P; Rodrigues, ED; Shokat, KM; Webb, P | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
2 other study(ies) available for harmalol and riboflavin
| Article | Year |
|---|---|
A surface on the androgen receptor that allosterically regulates coactivator binding.
Topics: Allosteric Site; Androgen Receptor Antagonists; Animals; Crystallography, X-Ray; In Vitro Techniques; Mice; Models, Molecular; Nuclear Receptor Coactivator 2; Protein Structure, Tertiary; Receptors, Androgen; Recombinant Proteins | 2007 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |